SAT-061 - Pituitary Apoplexy Presenting as Refractory Hyponatremia

A previously healthy 24-year-old man presented with subacute worsening headache. Initial evaluation revealed euvolemic hypotonic hyponatremia and central hypothyroidism. Brain magnetic resonance imaging (MRI) demonstrated a sellar lesion concerning for a Rathke cleft cyst versus hemorrhagic macroadenoma. His hyponatremia was initially attributed to syndrome of inappropriate antidiuretic hormone and treated with fluid restriction and hypertonic saline. However, his hyponatremia and neurologic symptoms worsened. Given the patient's headache and sellar pathology, pituitary apoplexy was considered. A pituitary panel was obtained and empiric hormone replacement therapy initiated with intravenous hydrocortisone (100 mg every 6 hours) and levothyroxine (100 mcg daily). His symptoms and laboratory abnormalities improved to near-complete resolution within 72 hours. Pituitary testing confirmed panhypopituitarism. The patient was discharged on levothyroxine and a hydrocortisone taper. A follow-up pituitary MRI demonstrated interval reduction in lesion size. At six-month follow-up, recovery of the pituitary axes were observed except for residual growth hormone deficiency. Pituitary apoplexy is a medical emergency requiring prompt recognition and initiation of hormone replacement therapy. Secondary adrenal failure may cause hyponatremia that is refractory to standard therapy thus mandating its consideration in this setting.

*Unless otherwise noted, all abstracts presented at ENDO must not be released to the press or the public until the date and time of presentation. For oral presentations, the abstracts are embargoed until the session begins. The Endocrine Society reserves the right to lift the embargo on specific abstracts that are selected for promotion prior to or during ENDO.*